(Q34303632)

1 August 2017

title

Alternative investigations for irritable bowel syndrome (English)

1 reference

1 August 2017

main subject

irritable bowel syndrome

1 reference

Hamish Philpott

1

1 reference

1 August 2017

Sanjay Nandurkar

series ordinal

2

1 reference

1 August 2017

John Lubel

series ordinal

3

1 reference

1 August 2017

Peter R Gibson

series ordinal

4

1 reference

1 August 2017

publication date

1 January 2013

1 reference

Journal of Gastroenterology and Hepatology

1 August 2017

published in

1 reference

1 August 2017

volume

28

1 reference

1 August 2017

issue

1

1 reference

1 August 2017

page(s)

73-77

1 reference

Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia.

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07291.X

How to read a paper. Papers that report diagnostic or screening tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07291.X

Testing for IgG4 against foods is not recommended as a diagnostic tool: EAACI Task Force Report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07291.X

Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07291.X

Roundtrip ticket for secretory IgA: role in mucosal homeostasis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07291.X

Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07291.X

Salivary IgA as a risk factor for upper respiratory infections in elite professional athletes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07291.X

The effects of examination stress on salivary cortisol, immunoglobulin A, and chromogranin A in nursing students

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07291.X

Alterations in intestinal permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07291.X

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07291.X

Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07291.X

Intestinal permeability and irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07291.X

Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07291.X

Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07291.X

A randomized controlled trial of Lactobacillus GG in children with functional abdominal pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07291.X

Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07291.X

Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07291.X

Wheat bran affects the site of fermentation of resistant starch and luminal indexes related to colon cancer risk: a study in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07291.X

Short-chain fatty acids and the irritable bowel syndrome: the effect of wheat bran

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07291.X

Effect of bran, ispaghula, and inert plastic particles on gastric emptying and small bowel transit in humans: the role of physical factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07291.X

Butyrate production from dietary fibre and protection against large bowel cancer in a rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07291.X

Colonic epithelial atrophy induced by a fibre-free diet in rats is reversed by minimal amounts of luminal butyrate, but only in the short term

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07291.X

Alterations in intestinal microbial flora and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07291.X

Rifaximin therapy for patients with irritable bowel syndrome without constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07291.X

Inflammation and microflora

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07291.X

A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07291.X

Meta-analysis of probiotics for the treatment of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07291.X

Effects of rifaximin treatment and retreatment in nonconstipated IBS subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07291.X

Enterotypes of the human gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07291.X

Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07291.X

A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07291.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07291.X

10.1111/J.1440-1746.2012.07291.X

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference